The Latest Updates for Healthcare and Biotech
- Why is US health care still the most expensive in the world after decades of cost-cutting initiatives? Feb 16, 2026 - By Patrick Aguilar, Washington University in St. Louis In announcing its “Great Healthcare Plan” in January 2026, the Trump administration became the… ...
- A billion-dollar drug was found in Easter Island soil – what scientists and companies owe the Indigenous people they studied Oct 7, 2025 - By Ted Powers, University of California, Davis An antibiotic discovered on Easter Island in 1964 sparked a billion-dollar pharmaceutical success story. Yet… ...
- RNA has newly identified role: Repairing serious DNA damage to maintain the genome Jun 19, 2025 - By Francesca Storici, Georgia Institute of Technology Your DNA is continually damaged by sources both inside and outside your body. One especially… ...
- Top Healthcare Companies scored from recent earnings including Humana May 30, 2025 - By InvestMacro Research Earnings season continues on and our latest update highlights some of the top companies that have been recently added… ...
- Massachusetts Biotech Advances Novel Cytokine Therapies Nov 16, 2023 - Source: Dr. Robert Driscoll (11/15/23) Wedbush sees over 300% upside for Werewolf stock based on early clinical success for its PREDATOR platform and… ...
- Telehealth Co. Signs Largest Client Yet Mar 30, 2023 - Source: Streetwise Reports (3/30/23) Onboarding will begin in April for the health care system that has more than 1,200 care centers in seven… ...
- Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered Mar 6, 2023 - By Dana Goldman, University of Southern California and Karen Van Nuys, University of Southern California Pharmaceutical giant Eli Lilly is slashing the… ...
- Exploring Why The Economist Named this Biotech ‘One To watch’ in 2023 Jan 24, 2023 - Source: Streetwise Reports (1/23/23) As more researchers delve into the medicinal potentials of once-verboten compounds, forward-thinking companies like Awakn Life Sciences Corp. are… ...
- Biopharma Co.’s Burn Tissue Removal Product Approved Jan 6, 2023 - Source: Swayampakula Ramakanth (1/4/23) Because of the green light from the U.S. Food and Drug Administration, H.C. Wainwright & Co. raised its target… ...
- Tech. Analyst Says Pharma Co. Is at a Favorable Risk/Reward Ratio Dec 29, 2022 - Source: Clive Maund (12/28/22) Technical analyst Clive Maund reviews Algernon Pharmaceuticals Inc.'s 6-month, 3-year, and 9-year charts to tell you whether you should… ...
- Biotech at Good Entry Point for Investors, Analyst Says Dec 21, 2022 - Source: Andrew Partheniou (12/20/22) The company, focused on psychedelic-assisted psychotherapies to better treat addiction, is worth more than the CA$10 million the market… ...
- Why One Fund Owns 13% of This Small-Cap Pharma Dec 14, 2022 - Source: Streetwise Reports (12/12/22) Clinical-stage Algernon Pharmaceuticals' multiple pipelines include testing a psychedelic for the treatment of stroke, and testing other drugs for… ...
- Biotech Co.’s Shares Soar to New 52-Week High Dec 8, 2022 - Source: Streetwise Reports (12/7/22) Prometheus Biosciences Inc. shares traded 170% higher to a new 52-week intraday high after the company reported positive results… ...
- Expert Says Health Tech Co. Is in Another Buy Spot Dec 1, 2022 - Source: Clive Maund (11/30/22) Expert Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you why he believes it is… ...
- Biopharma Co. Trades to New 52-Week High Nov 29, 2022 - Source: Streetwise Reports (11/28/22) Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successfully met… ...
- US Biopharma Co. Is Attractive, Derisked Investment, Analyst Says Nov 14, 2022 - Source: Streetwise Reports (11/11/22) With late-stage drug candidates and major near-term catalysts, undervalued Aldeyra Therapeutics warrants a Buy to Outperform rating and consideration… ...
- Expert Says Buy Pharma Co. Stock ‘as Soon as Possible’ Oct 28, 2022 - Source: Clive Maund (10/25/22) Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's attention. In light… ...
- Biopharma Co.’s Shares Roll to New 52-Week High Price Oct 14, 2022 - Source: Streetwise Reports (10/12/22) Shares of DICE Therapeutics Inc. traded 62% higher yesterday and established a new 52-week intraday high after the company… ...
- Biopharma Co. Partners With Merck for Combo Drug Trial Oct 13, 2022 - Source: Dr. Joseph Pantginis (10/12/22) With this and other clinical studies, the U.S. company has a busy and, thus, catalyst-rich Q4/22 ahead, noted… ...
- Trial Results Show New Drug Improves Dry Eye Symptoms Jul 20, 2022 - These study data from Aldeyra Therapeutics Inc. solidified the therapeutic's path to filing a new drug application, potentially in Q3/22, noted an… ...
- Biopharma Co. Looks to Expand New Drug Label Down the Road Jul 20, 2022 - ScPharmaceuticals Inc. just released topline results from a Phase 2 pilot study supporting the drug developer that is pursuing the expansion of… ...
- Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity Jul 20, 2022 - Source: Streetwise Reports 07/18/2022 One junior biotech company that attempts to treat current health problems with older previously approved drugs, recently completed… ...
- Why are drug names so long and complicated? A pharmacist explains the logic behind the nomenclature Jul 19, 2022 - By Jasmine Cutler, University of South Florida At some point in your life, you’ll likely find yourself with a prescription from your… ...
- Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’ Jul 18, 2022 - Source: Patrick Trucchio 07/15/2022 Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD)… ...
- Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry Jul 18, 2022 - Source: Jason McCarthy 07/14/2022 One healthcare co. is currently rated a Buy and is making a push for a share of the… ...
- Pharma Co. Reduces Mortality Rates by 70% in ALS Trial Jul 18, 2022 - Source: Streetwise Reports 07/15/2022 Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to… ...
- Biopharma Co. Posts 17% BMI Reduction in Ph. 2 Trial Jul 18, 2022 - Source: Streetwise Reports 07/14/2022 Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its… ...
- Analyst Sees ‘Attractive Long-Term Economics’ for Healthcare Co. Jul 15, 2022 - Source: Andrew Partheniou 07/13/2022 One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with… ...
- Results of Dermatitis Clinical Trial Due This Summer Jun 23, 2022 - Enrollment is now done for VYNE Therapeutics Inc.'s Phase 2a trial following encouraging Phase 1b efficacy data, noted an H.C. Wainwright &… ...
- New Positive Data Seem to Support Drug Label Expansion Jun 23, 2022 - Checkpoint Therapeutics Inc., the biopharma behind this late-stage monoclonal antibody for metastatic cutaneous squamous cell carcinoma, could use the new trial results… ...
